Clinical Trial Results: Effect of Obesity on Proton Pump Inhibitors [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of obesity on proton pump inhibitors in pediatric obesity and NAFLD with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Nonalcoholic Fatty Liver Disease
• Obesity

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Pediatric Obesity, NAFLD | Phase 4 | Status: COMPLETED | Results posted: 2026-06-04